Why it was recalled
Presence of Foreign Substance: presence of particles and white flakes in the reconstituted bottles.
Product description
CLINDAMYCIN PALMITATE HYDROCHLORIDE FOR ORAL SOLUTION, USP, 75 mg/5 mL, Rx Only, 100 mL, Distributed by: Avet Pharmaceuticals Inc., East Brunswick, NJ 08816, NDC 23155-603-51
Lot numbers, UPCs & expiration codes
Lot #: 2411550, Exp. 2026/NOV.
Where it was sold
Nationwide within the U.S
What to do if you have this product
- Compare the lot number and expiration date on your package with the codes above.
- Don't stop taking a prescription medicine on your own. Call your pharmacist or doctor; they can confirm whether your supply is affected and arrange a replacement.
- If you have symptoms you think are related, contact your doctor. In an emergency call 911.
- Report side effects to FDA MedWatch at 1-800-FDA-1088.
Recall details
- Recall number
- D-0768-2026
- Classification
- Class II
- Status
- Ongoing
- Recall initiated
- Jul 30, 2026
- FDA report date
- Aug 19, 2026
- Recall type
- Voluntary: Firm initiated
- Recalling firm
- Heritage Pharmaceuticals Inc
Original FDA data
Every field from FDA enforcement report D-0768-2026, exactly as published.
Show all FDA fields
- City
- East Brunswick
- State
- NJ
- Status
- Ongoing
- Country
- United States
- Event ID
- 99526
- Address
- 1 Tower Center Blvd Ste 1700
- Code information
- Lot #: 2411550, Exp. 2026/NOV.
- Postal code
- 08816-1145
- Report date
- Aug 19, 2026
- Product type
- Drugs
- Recall number
- D-0768-2026
- Classification
- Class II
- Recalling firm
- Heritage Pharmaceuticals Inc
- Reason for recall
- Presence of Foreign Substance: presence of particles and white flakes in the reconstituted bottles.
- Voluntary / mandated
- Voluntary: Firm initiated
- Product description
- CLINDAMYCIN PALMITATE HYDROCHLORIDE FOR ORAL SOLUTION, USP, 75 mg/5 mL, Rx Only, 100 mL, Distributed by: Avet Pharmaceuticals Inc., East Brunswick, NJ 08816, NDC 23155-603-51
- Distribution pattern
- Nationwide within the U.S
- Recall initiation date
- Jul 30, 2026
- Initial firm notification
- Letter
- Center classification date
- Aug 14, 2026